Hikma Pharmaceuticals (HIK) Insider Trading & Ownership

GBX 1,838.19
+25.19 (+1.39%)
(As of 05:24 PM ET)

Hikma Pharmaceuticals (LON:HIK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
30.72%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
£27,300.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get HIK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Hikma Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HIK Insider Buying and Selling by Quarter

Hikma Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2023Douglas HurtInsiderBuy1,500GBX 1,820£27,300
(Data available from 1/1/2013 forward)

HIK Insider Trading Activity - Frequently Asked Questions

Who is on Hikma Pharmaceuticals's Insider Roster?

The list of insiders at Hikma Pharmaceuticals includes Deneen Vojta, Douglas Hurt, and Sigurdur Olafsson. Learn more on insiders at HIK.

What percentage of Hikma Pharmaceuticals stock is owned by insiders?

30.72% of Hikma Pharmaceuticals stock is owned by insiders. Learn more on HIK's insider holdings.

Which Hikma Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased HIK shares in the last 24 months: Deneen Vojta (£17,030), and Douglas Hurt (£27,300).

How much insider buying is happening at Hikma Pharmaceuticals?

Insiders have purchased a total of 2,500 HIK shares in the last 24 months for a total of £44,330 bought.


More Insider Trading Tools from MarketBeat

This page (LON:HIK) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners